Skip to main content

Table 1 Characteristics of the six patients with rheumatoid arthritis and sinus aspergilloma

From: Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

Case RA durationa (years) Age at aspergilloma onset (years) Co-morbidities Previous RA treatment other than TNFα antagonists TNFα antagonist, date Surgery for RA
1 17 53 Hepatitis, hypertension, hypothyroidism, gastric ulcer, bronchiectasis Glucocorticoid therapy, methotrexate, leflunomide Infliximab, March 2003 No
2 32 66 Hypertension, tuberculosis, osteoporosis, uveitis, coronary artery disease Glucocorticoid therapy, methotrexate Infliximab, November 2001 Yes
3 15 47 Primary tuberculosis, iron-deficiency anemia Glucocorticoid therapy, methotrexate, leflunomide, salazopyrine Etanercept, February 2003 Yes
4 39 70 Hypertension Glucocorticoid therapy, methotrexate Infliximab, March 2002; etanercept, July 2003 No
5 15 53 -- Glucocorticoid therapy, methotrexate, salazopyrine, hydroxychloroquine -- Yes
6 12 52 Chronic hepatitis B, iron-deficiency anemia, osteopenia Glucocorticoid therapy, methotrexate, salazopyrine -- Yes
  1. aRheumatoid arthritis (RA) duration at aspergilloma diagnosis.